Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (3742)	11/22/1999 3:32:00 PM
From: KS	Read Replies (2) \| Respond to of 6039

CTI Signs Agreement with Latin American Consortium LAYTON, Utah--(BUSINESS WIRE)--Nov. 22, 1999--Computerized Thermal Imaging Inc. (OTC Bulletin Board: COII - news) announced today that it has signed an engagement letter with a consortium of Latin American investors and service providers. The consortium known as Computerized Thermal Imaging International becomes CTI's key in the consortium's exclusive deployment throughout Latin America. A key member of the consortium, Pegaso PCS, S.A. de C.V. has agreed to work with CTI International to provide system wide connectivity beginning in Mexico. Computerized Thermal Imaging International has made a firm commitment to the purchase of 100 CTI diagnostic systems valued at approximately US$50,000,000 over a two-year period. It is expected that about 40 of these units can be deployed in Mexico beginning in the second quarter of 2000. "I am pleased to have this consortium as a part of our growing strategic team," said David Packer, president of CTI. "This relationship will enable us to start moving our technology into Latin America. Meanwhile we continue to move through clinical trials in the U.S. so as to obtain FDA approval as soon as possible. I estimate that the first 40 systems will be deployed to Mexico by the time of our anticipated FDA PMA approval." CTI systems will be interconnected throughout Mexico utilizing the Pegaso PCS network. Pegaso is deploying the first 100% digital network in Mexico with a planned initial investment of approximately $1.3 billion. Pegaso plans to offer nationwide PCS service, launching in the country's four largest cities in 1999. Pegaso has already introduced service in Monterrey, Guadalajara and Tijuana and plans to launch in Mexico City later this year. Mr. Alejandro Diez Barroso, President, of Pegaso says, "We think this agreement with CTI is a very important addition to our providing connectivity to businesses throughout Mexico. We are pleased to have been chosen by CTI as a partner." Computerized Thermal Imaging, Inc. develops and deploys thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. It is currently seeking FDA approval for the use of the Computerized Thermal Imaging System as an adjunctive diagnostic test to the mammogram and clinical examination for the detection of breast cancer. CTI currently has FDA trials underway at the following locations: Providence Hospital in Washington DC, Mt. Sinai Cancer Center in Miami Beach, Florida, Norris Cancer Hospital in Los Angeles, CA, St. Agnes Hospital in Baltimore, MD, and Lahey Clinic in Peabody, MA. Selection of future locations is currently underway. The test is simple, painless and involves no radiation, breast compression, electrodes or electrical current. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at 801-926-1113. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC. CONTACT: Computerized Thermal Imaging, Inc., Layton Dee Rose 801-926-1113